What is IgniteData?
IgniteData is at the forefront of revolutionizing clinical trial data integration through its proprietary technology, Archer. This platform is engineered to facilitate the seamless and secure transfer of patient data from hospitals, thereby minimizing errors and enhancing operational efficiency through automated data collection. By bridging the gap between electronic health records and electronic data capture systems, IgniteData primarily serves hospitals and clinical trial sponsors. Its core mission is to modernize clinical trials by enabling robust interoperability across diverse healthcare data systems. Founded in 2014, the company's focus on data management efficiency positions it as a key player in the health-tech sector.
How much funding has IgniteData raised?
IgniteData has raised a total of $10.9M across 3 funding rounds:
Multiple Rounds
$10.9M
Private Equity (2025): $8.1M, investors not publicly disclosed
Private Equity (2025): $1.1M, investors not publicly disclosed
Private Equity (2025): $1.7M, investors not publicly disclosed
What's next for IgniteData?
The substantial enterprise-level funding IgniteData has garnered, particularly the recent strategic investment, signals a strong validation of its technological approach and market potential. This influx of capital is likely to accelerate the company's growth trajectory, enabling further development of its Archer platform and expansion into new markets. IgniteData is poised to deepen its impact on clinical trial efficiency and data integrity, potentially solidifying its position as an indispensable partner for hospitals and pharmaceutical companies seeking to streamline their research and development pipelines. The company's ability to secure such significant backing suggests a robust strategy for scaling operations and enhancing its competitive advantage in the rapidly evolving health-tech landscape.
See full IgniteData company page
